UnitedHealth Group Inc

Most Recent

  • How Does Aetna Compare to Its Peers in Medical Care Ratio?
    Company & Industry Overviews

    How Does Aetna Compare to Its Peers in Medical Care Ratio?

    The medical care ratio of health insurance companies is calculated as the ratio of the total money spent in health care claims to premiums earned.

    By Margaret Patrick
  • uploads///Chart  NMDA
    Company & Industry Overviews

    What Are Sage Therapeutics’ Receptor-Based Products?

    Sage Therapeutics (SAGE) is focused on the development of the products for the treatment of life-threatening central nervous system (or CNS) disorders.

    By Mike Benson
  • uploads///Graph
    Earnings Report

    Analysts’ Recommendations for Anthem in 2017

    Based on the company’s performance in 1Q17, Anthem (ANTM) has increased its 2017 revenue guidance by around $1.5 billion.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    What’s UnitedHealth Group’s outlook for 2015?

    It’s projected that UnitedHealth Group’s revenue and earnings growth in 2015 will be driven by the strong performance of the Optum segments.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Enrollments decreased in UnitedHealth’s international business

    In the US, the private health insurance industry has been expanding its footprint in international markets. International markets are less penetrated and competitive.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    UnitedHealth Group’s Optum segment: Earnings rose in 2014

    UnitedHealth Group (UNH) operates Optum. It provides health services like health technology, health and well-being, and pharmacy services.

    By Margaret Patrick
  • uploads///valuation
    Company & Industry Overviews

    How Does UNH’s Valuation Look in October?

    UnitedHealth Group is a leading managed healthcare firm in the United States.

    By Sarah Collins
  • uploads///HUM
    Fund Managers

    Eminence Capital Reduces Position in Humana

    During the fourth quarter of 2014, Eminence Capital lowered its stake in Humana (HUM). The company accounted for 1.33% of the fund’s 4Q14 portfolio.

    By Diana Key
  • uploads///Graph
    Earnings Report

    Humana’s core business: The Medicare Advantage program

    Humana’s total enrollment is mainly enrollments in the MA program, a substitute for the original Medicare program, via private insurance companies.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Why UnitedHealth Group Plans to Reduce Its Public Exchange Exposure

    Given the high-risk profile of individual exchange enrollments, UnitedHealth Group has decided to offer plans only on a few public exchanges in 2017.

    By Margaret Patrick
  • uploads///Chart
    Company & Industry Overviews

    Decoding Humana’s Revenue Stream in 2015

    Humana reported revenues of about $54.3 billion in its 2015 results. This amounts to a 12% revenue growth in 2015, compared to ~$48.1 billion in 2014.

    By Mike Benson
  • uploads///capital plan
    Company & Industry Overviews

    UnitedHealth Group Goes Ex-Dividend Today

    UnitedHealth Group (UNH) has announced that its board of directors has authorized a cash dividend of $0.90 per share.

    By Sarah Collins
  • uploads///family _
    Company & Industry Overviews

    UNH’s Stock Price Performance in June

    On June 28, UnitedHealth Group (UNH) ended the trading day at $244.90, ~4.6% lower than its 52-week low of $183.86 reached on July 18, 2017.

    By Sarah Collins
  • uploads///rawpixel  unsplash
    Earnings Report

    UNH Stock Up 4.1% on Solid Q3 2018 Results, View Up

    UnitedHealth Group (UNH) released its Q3 2018 earnings today. UNH reported sales of $56.6 billion, up ~12.4% on a year-over-year basis.

    By Sarah Collins
  • uploads///HUM AET downside
    Miscellaneous

    What Is the Risk-to-Reward Ratio of the Humana–Aetna Deal?

    Scenario analysis  In the risk-arbitrage world, a 12.2% expected return means a deal that has a lot of risk. Arbitrageurs sometimes refer to risk as “hair.” This deal is guaranteed a second request, and the regulators may simply be unable to get comfortable with the transaction, no matter what the companies offer in the way […]

    By Brent Nyitray, CFA, MBA
  • uploads///recommendation
    Company & Industry Overviews

    Jefferies Raised Its Target Price on UNH Stock: What’s the Outlook?

    UnitedHealth Group (UNH) is one of the largest Fortune 500 companies.

    By Sarah Collins
  • uploads///BUSINESS POSITIONING
    Earnings Report

    How Is UNH’s Optum Business Positioned in the Industry?

    UnitedHealth Group is, by revenue, the largest healthcare company in the world.

    By Sarah Collins
  • uploads///business _
    Earnings Report

    UnitedHealth Group Reports Q2 2018 Earnings, Stock Down 1.9%

    Today, UnitedHealth Group (UNH) reported its earnings results for the second quarter of fiscal 2018. The company reported sales of $56.1 billion, up ~12% on a (year-over-year) basis.

    By Sarah Collins
  • uploads///Graph
    Miscellaneous

    Negative Sentiment Will Impact Health Insurance Companies

    The healthcare bill’s failure had a negative impact on investor sentiment for health insurance carriers.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    UnitedHealth Group Posted 4Q15 Earnings: What You Should Know

    UnitedHealth Group (UNH) released its 4Q15 and full year 2015 earnings on January 19, 2015. The company registered diluted EPS attributable to common shareholders of $1.26 in 4Q15 and $6 for 2015.

    By Margaret Patrick
  • uploads///family insurance _
    Company & Industry Overviews

    UnitedHealth Group Stock at 52-Week High, Up 22% Year-to-Date

    UnitedHealth Group (UNH) stock registered its 52-week high of $270.17 last week on August 30.

    By Sarah Collins
  • uploads///family __
    Earnings Report

    Analyst Ratings for UnitedHealth before Q3 2018 Earnings

    Of the 24 analysts covering UNH stock, ten have recommended a “strong buy,” and 13 have recommended a “buy.”

    By Sarah Collins
  • uploads///people _
    Financials

    Why Envision Healthcare Stock Rose ~2.4% Last Week

    Healthcare service provider Envision Healthcare (EVHC) announced its agreement to be acquired by KKR (KKR) last week.

    By Mike Benson
  • unitedhealth earnings call
    Healthcare

    UnitedHealth Posts Outstanding Q3 Results, Beats Expectations

    By Ambrish Shah
  • When Is UnitedHealth Earnings Date?
    Financials

    Will UnitedHealth’s Q3 Earnings Boost Its Stock Price?

    By Ambrish Shah
  • uploads///STOCK PRICE
    Company & Industry Overviews

    UnitedHealth Group’s Recent Stock Performance

    On March 14, 2018, UnitedHealth Group (UNH) ended trading at $225.38 per share.

    By Sarah Collins
  • uploads///Vanguard  Index Fund Investor Class VFINX
    Company & Industry Overviews

    US Stock Indexes Fell as Oil Prices Touched New Lows

    Three US equity indexes—the S&P 500, the Dow Jones Industrial Average, and the NASDAQ—fell from January 12 to January 19 as the oil price rout continued.

    By Lynn Noah
  • uploads///A doctor showing a patient a syringe used to inject testosterone
    Healthcare

    ‘Medicare for All’ Is No Reason to Drop Healthcare Stocks

    While the media caters to Millennial preferences, there’s one economic sector that’s shifting to a more seasoned crowd: healthcare stocks.

    By David Moadel
  • uploads///stock picture HJHQsQohM
    Consumer

    Wellington Management: Analyzing Its Top Holdings

    Wellington Management filed its 13F on Wednesday. Based on the filing, the market value of total publicly traded securities was around $443.45 billion.

    By Rabindra Samanta
  • uploads///stock trading monitor desk
    Consumer

    Renaissance Technologies: Analyzing Its Q3 13F

    At the end of the third quarter, Bristol-Myers Squibb, Celgene, Biogen, UnitedHealth, and Walmart (WMT) were Renaissance Technologies’ top five buys.

    By Rabindra Samanta
  • uploads///Dow Jones
    Consumer

    Will the Dow Jones Crash by the end of 2019?

    The Dow Jones Industrial Index (or DJIA) is trading just 2.2% below its all-time high. But is the stock bubble about to burst?

    By Adam Rogers
  • uploads///DOW JONE
    Healthcare

    Dow Jones and SPY Trade Lower, Retail Data Disappoints

    All of the major indexes and ETFs are trading lower today. The Dow Jones Industrial Average has fallen by 44 points or 0.16% at the time of this writing.

    By Adam Rogers
  • uploads///DOW JONES
    Financials

    Dow Jones Gains 300 Points, United Health Rises 8%

    The Dow Jones Industrial Index has gained close to 300 points today. The earnings season kicked-off. Several companies reported their quarterly results.

    By Adam Rogers
  • uploads///APPLE
    Consumer

    Apple Stock Gains 50%, Drives Dow Jones Higher in 2019

    Apple (AAPL) shares have gained close to 50% year-to-date. The stock is trading at $235.87, while it’s valued at $1.07 trillion.

    By Adam Rogers
  • uploads///DOW JONES
    Consumer

    Dow Jones Ends Volatile Week in Red

    The Dow Jones Industrial Index (or DJIA) fell 0.4% or 114 points in the last week. The DJIA is currently trading 2.1% below its 52-week high.

    By Adam Rogers
  • uploads///DOW JONES
    Financials

    Dow Jones Reverses Early Gains, Falls 0.2% Today

    The Dow Jones Industrial Average fell 53.44 points (or 0.2%) today, possibly because the market gave a thumbs up to yesterday’s 0.25% rate cut by the Fed.

    By Adam Rogers
  • uploads///Fed Cuts Rate
    Consumer

    Stock Market Fell despite the Fed’s Rate Cut

    The broader stock market fell on Wednesday despite the Fed’s rate cut. The Dow Jones and S&P 500 indexes marked the biggest single-day drop since May 31.

    By Anirudha Bhagat
  • uploads///coins _
    Company & Industry Overviews

    Will UnitedHealth Group Report Strong Q2 Earnings?

    On Thursday, UnitedHealth Group (UNH) is scheduled to release its second-quarter earnings. The company will release its earnings before the market opens.

    By Margaret Patrick
  • uploads///adult career clipboard
    Company & Industry Overviews

    This Rebate Decision Saw Health Insurers Soar Yesterday

    On Thursday, the Trump administration announced the withdrawal of the proposal to abolish rebates paid to pharmacy benefit managers by drugmakers.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    UNH’s Medicaid Business: Analyzing Trends in Q1

    In the first quarter, UnitedHealth Group reported Medicaid membership of 6.42 million—a decline of 25,000 members YoY.

    By Margaret Patrick
  • uploads///doctor medical medicine health
    Earnings Report

    UnitedHealth Group: Analysts’ Ratings after Its Q1 Results

    On April 16, UnitedHealth Group (UNH) closed at $220.96, which was 4.01% lower than its previous closing price.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Optum Is a Major Differentiator for UnitedHealth Group

    In fiscal 2018, UnitedHealth Group’s (UNH) health services business, Optum, reported revenues of $101.3 billion, a YoY rise of 11.07%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    CNC or UNH: Who Has Better Earnings Growth Prospects?

    In its fourth-quarter earnings conference call, Centene (CNC) guided for fiscal 2019 GAAP diluted EPS of $3.65–$3.83.

    By Margaret Patrick
  • uploads///insurance _
    Earnings Report

    UnitedHealth Group’s Performance in Fiscal 2018

    In UnitedHealth Group’s (UNH) fourth-quarter earnings release, the company announced its fiscal 2018 revenues of $226.2 billion.

    By Margaret Patrick
  • uploads///human skeleton _
    Company & Industry Overviews

    United Health Group Stock Has Risen 28% in 2018

    On November 29, United Health Group’s (UNH) stock price closed at $282.55, which is ~8% growth from its close of $261.62 on November 23.

    By Daniel Collins
  • uploads///business _
    Healthcare

    Wall Street Expects 9% Upside Potential for UnitedHealth Stock

    As of September 24, ten of the 24 analysts covering UNH stock have given it a “strong buy” recommendation.

    By Sarah Collins
  • uploads///Chart
    Company & Industry Overviews

    Estimates and Recommendations for DaVita on September 17

    Analysts estimate that DaVita (DVA) will report a 25.3% decline in revenues to $11.6 billion in 2018 compared to $15.5 billion in 2017.

    By Mike Benson
  • uploads///medic _
    Company & Industry Overviews

    DaVita’s Valuation on September 17

    DaVita currently trades at a forward PE multiple of 15.2x compared to the industry average of 15.1x as of September 17.

    By Mike Benson
  • uploads///recommendation
    Company & Industry Overviews

    Analysts Raise Target Prices on UNH Stock in September

    Of the 23 analysts covering UNH stock, all of them have “buy” or “strong buy” recommendations for UnitedHealth Group.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    BSX Focuses on Advancing Its Cardiac Rhythm Management Portfolio

    Boston Scientific expects the results from its UNTOUCHED trial by 2020.

    By Margaret Patrick
  • uploads///Chart
    Company & Industry Overviews

    Envision Healthcare to Be Acquired by KKR

    On June 11, Envision entered into a definitive acquisition agreement with KKR.

    By Mike Benson
  • uploads///healthcre
    Healthcare

    How the Healthcare Sector’s Dividend Yield Stacks Up

    The healthcare industry has an average dividend yield of 1.9%.

    By Amanda Lawrence
  • uploads///insurance _
    Earnings Report

    UnitedHealth Group Posted Strong 1Q18 Performance

    On April 17, UnitedHealth Group (UNH) reported its 1Q18 earnings results. UNH stock rose ~3.6% from its April 16 closing price.

    By Sarah Collins
  • uploads///BUSINESS POSITIONING
    Company & Industry Overviews

    UnitedHealth Group Drops Out of the Bid to Acquire Envision

    On March 14, 2018, it was reported that UnitedHealth Group is no longer interested in acquiring Envision Healthcare

    By Sarah Collins
  • uploads///hands _
    Healthcare

    Cigna Expects Acquisition of Express Scripts by End of 2018

    On March 7, 2018, Cigna (CI) announced that it has entered into a definitive agreement to acquire Express Scripts (ESRX) for $67 billion.

    By Margaret Patrick
  • uploads///XLV
    Fund Managers

    What to Expect from the Healthcare Sector in 2H17

    The healthcare sector has been the second-largest gainer in the S&P 500 Index (SPY) so far this year.

    By Sarah Sands
  • uploads///djiaconsti
    Consumer

    How the Dow Jones Industrial Average Has Performed

    The Dow Jones Industrial Average Index has a YTD return of 10.5%. It offers a dividend yield of 2.4% at a PE (price-to-earnings) ratio of 20.4x.

    By Amanda Lawrence
  • uploads///Chart  Oncology
    Earnings Report

    Eli Lilly in 2Q17: Oncology Products Lose Revenues

    Alimta sales fell ~12.0% to $532.9 million in 2Q17 compared to $607.1 million in 2Q16.

    By Mike Benson
  • uploads///Chart  Revenues
    Company & Industry Overviews

    Bristol-Myers Squibb Reported Revenue Growth in 1Q17

    Bristol-Myers Squibb (BMY) reported 12% growth in its top line to ~$4.93 billion during 1Q17 due to 13% operational growth in its revenues

    By Mike Benson
  • uploads///Graph
    Miscellaneous

    Health Sector Overview: Week of June 5–9, 2017

    In the week ending June 9, 2017, the Health Care Select Sector SPDR Fund (XLV) saw a rise of 0.13%.

    By Margaret Patrick
  • uploads///Chart  Endo
    Company & Industry Overviews

    Performance of Eli Lilly’s Endocrine Products in 1Q17

    Humalog reported growth of 17% to $708.4 million during 1Q17, compared to $606.3 million for 1Q16.

    By Mike Benson
  • uploads///Part  MMM
    Company & Industry Overviews

    3M Gets Order from the United States Army

    On May 18, 2017, 3M (MMM) said it received orders from the United States Army for PELTOR TEP-100 earplug kits and PELTOR ComTac communication headsets.

    By Peter Neil
  • uploads///Graph
    Company & Industry Overviews

    Medicare Business Expected to Drive WellCare Health Plans’ Margin Growth

    In 1Q17, WellCare Health Plans’ (WCG) Medicare Health Plans business reported revenues close to $1.1 billion, which represents year-over-year growth of ~12.4%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Medicaid Business—A Key Revenue Driver for WellCare Health Plans in 2017

    In 1Q17, WellCare Health Plans’ (WCG) Medicaid business reported revenues close to $2.6 billion, which equals year-over-year growth of ~11.8%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Analysts’ Recommendations for WellCare Health Plans in May 2017

    On April 28, 2017, WellCare Health Plans (WCG) completed the acquisition of Universal American Corp. This deal added 119,000 Medicare Advantage members from several major markets

    By Margaret Patrick
  • uploads///Healthcare Moves Have Been Muted Compared to Biotech
    Real Insights

    Healthcare Moves Have Been Muted, but Could We Get a Surprise?

    Rising interest rates don’t negatively affect healthcare as much as some other industries. But it has still underperformed since the US elections.

    By Direxion
  • uploads///Chart  Development
    Earnings Report

    Eli Lilly & Co.’s Developments in 1Q17

    In 1Q17, Eli Lilly and Boehringer Ingelheim launched Synjardy XR tablets in the US for patients with type 2 diabetes.

    By Mike Benson
  • uploads///Graph
    Earnings Report

    Why Centene’s Health Benefit Ratio Improved in 1Q17

    Centene (CNC) has projected its health benefit ratio (or HBR) for the full year 2017 to fall in the range of 87.0% to 87.5%.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Centene Saw Robust Rise in Medicaid Enrollments in 1Q17

    In 1Q17, around 12.1 million members were enrolled in Centene’s (CNC) various healthcare plans, which is a year-over-year (or YoY) rise of around 600,000 beneficiaries.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    UnitedHealth Group Witnessed Robust Customer Growth in 1Q17

    In 1Q17, UnitedHealth Group’s (UNH) UnitedHealthcare business witnessed a 2.5 million year-over-year increase in customers.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    OptumRx Continues to Boost UnitedHealth’s Pharmacy Care Services

    In its bid to control healthcare costs, UnitedHealth Group’s (UNH) OptumRx segment has been actively deploying data analytics across its Optum platform.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Optum360: Will It Become UnitedHealth’s Key Growth Driver?

    Optum360, UnitedHealth Group’s (UNH) hospital revenue cycle management solution, is expected to reach $60.0 billion in billings for clients and partner organizations.

    By Margaret Patrick
  • uploads///obamacare
    Macroeconomic Analysis

    How Could Trump’s Presidency Affect Hospitals and Insurance?

    The effects of repealing Obamacare Donald Trump is definitely not in favor of the Affordable Care Act, known as Obamacare. As he wants to repeal the act completely and replace it with another policy, the hospital sector fell on November 9, the day after the election. Trump believes that providing healthcare facilities to illegal immigrants costs […]

    By Jillian Dabney
  • Company & Industry Overviews

    Why Is the ClearBridge Aggressive Growth Fund Lagging behind Peers?

    SHRAX has been a below average YTD performer. The past year until October 14 was hard on the fund. It placed dead last among the 12 peers in this review.

    By David Ashworth
  • Basic Materials

    What Saved the Day for the ClearBridge Aggressive Growth Fund?

    The ClearBridge Aggressive Growth Fund Class A has risen by 1.6% in 2016. This places it right in the middle of the pack of our 12 funds in this review.

    By David Ashworth
  • uploads///part
    Company & Industry Overviews

    How 3M Company’s Products Look After Your Health

    Revenues from 3M Company’s (MMM) Healthcare segment rose from 16.7% ($5 billion) of total annual revenue in 2011 to 17.5% ($5.4 billion) in 2015.

    By Shannon Black
  • uploads///Graph
    Earnings Report

    Behind OptumHealth’s and OptumInsight’s Strong Revenue Growth in 1Q16

    UnitedHealth Group’s healthcare delivery business, OptumHealth, managed to earn $4 billion revenues in 1Q16, which represents a YoY growth of about 22%.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    What You’ll Want to Know about Anthem’s Guidance for 2016

    In its 1Q16 conference call, Anthem updated its 2016 revenue guidance to $81 billion–$82 billion—higher than the previous projection by about $1 billion.

    By Margaret Patrick
  • Company & Industry Overviews

    Information Technology, Energy Helped AMCPX Have a Superb 1Q16

    The American Funds AMCAP Fund Class A (AMCPX) rose 0.4% in 1Q16. In the past year, the fund rose 1.2%, again the highest among its peers.

    By David Ashworth
  • uploads///Graph
    Earnings Report

    What Subsidy Eligible Membership Could Mean for Centene’s Public Exchange Revenues

    Centene managed to increase its public exchange membership from 75,000 members in 2015 to 146,000 members in 2015.

    By Margaret Patrick
  • uploads///Performances of Healthcare Stocks
    Macroeconomic Analysis

    SPY Heavy as UnitedHealth Group Forewarned Profit

    The Health Care Select Sector SPDR ETF tumbled -1.7% on November 19 after UnitedHealth Group lowered its profit expectations for 2015 and cut its earnings forecast.

    By Renee Blakely
  • uploads///Graph
    Earnings Report

    What Are UnitedHealth Group’s Growth Opportunities?

    To strengthen their presence in international markets, health insurance companies have been involved in mergers and acquisitions with local insurance companies in these markets.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Why UnitedHealth Group’s Net Profit Margins Fell

    In 3Q15, despite a rise of total revenues by 27% year-over-year, which includes 10% organic growth, UnitedHealth Group reported a decline of about 1% in net profit margins.

    By Margaret Patrick
  • uploads///SPDR Barclays High Yield Bond ETF JNK
    Company & Industry Overviews

    Uncertainty Moved US Financial Markets Last Week

    US financial markets were unable to make up their minds last week about the possible outcome of the Federal Reserve meeting.

    By David Ashworth
  • uploads///Graph Part
    Company & Industry Overviews

    PerkinElmer and Mallinckrodt Help Bottom Ten Stocks in XLV

    PerkinElmer (PKI) with a return of 5.94% was the best performer of XLV’s bottom ten stocks.

    By Peter Neil
  • uploads///US Treasuries Yield Curve
    Company & Industry Overviews

    Is the Treasury Yield Curve Getting Flatter?

    For corporates issuing high-grade bonds, the yield curve getting flatter can lead to issuance of longer-duration bonds.

    By David Ashworth
  • uploads///Graph
    Miscellaneous

    Is UnitedHealth Group a Better Partner for Cigna?

    Based on market capitalization, UnitedHealth Group appears to be a stronger partner for Cigna.

    By Margaret Patrick
  • uploads///Graph
    Miscellaneous

    Centene–Health Net Entity Could Be Medicaid Leader

    Centene aims to position itself as a leader in the fast-growing Medicaid market. Health Net’s acquisition will add ~1.7 million Medicaid members to the company’s portfolio.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Humana’s Commercial Enrollments Face Pressure in 1Q15

    Humana’s (HUM) revenues from commercial enrollments increased by 28.4%, from $2.2 billion in 1Q14 to $2.8 billion in 1Q15.

    By Margaret Patrick
  • uploads///Market Reaction on FOMC Statement April
    Macroeconomic Analysis

    Should Markets Be Happy or Worried about April FOMC Statement?

    Should the markets be happy about a later-than-expected rate hike? Or should they be worried that the FOMC’s optimism may spell the end of their golden run?

    By David Ashworth
  • uploads///industry performance over last  years
    Macroeconomic Analysis

    What Stage of the Business Cycle Are We In Now?

    Looking at the US economy for the last three years might help us understand which phase of the business cycle the US economy is in right now.

    By Surbhi Jain
  • uploads///Graph
    Earnings Report

    Key Takeaways from UnitedHealth Group 1Q15 Earnings

    UnitedHealth Group (UNH) posted its 1Q15 earnings on April 16, 2015. Following the release, UnitedHealth Group’s share price increased by 3.6%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What Are Centene’s Key Risks?

    Centene (CNC) faces a unique combination of business risks as well as risks specific to the health industry (IYH). Centene has a highly concentrated business mix.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Anthem: Mergers and Acquisitions Target Medicaid, Medicare

    Anthem’s mergers and acquisitions strategy mainly targets the company’s government-sponsored business.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Medical Care Ratio – Centene Compared to Its Peers

    For health insurance companies, the medical care ratio is the ratio of total money spent on healthcare claims to premiums earned—adjusted for tax and regulatory expenses.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Anthem’s Medical Care Ratio Improves, Boosts Profit Margin

    Anthem’s medical care ratio declined from 87.8% in 2013 to 83.1% in 2014, as a result of its favorable enrollment mix.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Specialty Services: How Does Centene Manage Them?

    Aside from the standard healthcare policies, players—like Centene—in the private health insurance industry (IYH) also offer specialty insurance.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What’s Centene’s Business Strategy?

    Centene’s business strategy focuses on improving the quality of its services. It provides services to the uninsured and underinsured population in 22 states in the US.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cigna: Global Supplemental Benefits Earn 9% of Revenues

    Cigna’s (CI) Global Supplemental Benefits segment accounts for about 9% of the company’s total revenues.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cigna: International Expansion Key to Growth Strategy

    International expansion is a hallmark of Cigna’s business. Cigna has inked deals in Turkey, Belgium, Brazil, Japan, Taiwan, Thailand, et cetera.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.